Showing results (111-120 of 10,058) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|July 19, 2016
Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer TherapyYi-Chao Zheng, Jin-Lian Ma, Ying Liu, et al.Current Pharmaceutical Design|July 14, 2015
The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology DrugsJavier A MenendezCurrent Pharmaceutical Design|July 7, 2015
Obstructive Sleep Apnea and Cardiovascular Disease - A New Target for TreatmentGiuseppe Schillaci, Francesca Battista, Giuseppe Fiorenzano, et al.Current Pharmaceutical Design|July 7, 2015
Disruption of Circadian Rhythms and Sleep on Critical Illness and the Impact on Cardiovascular EventsCristine J Reitz, Tami A MartinoCurrent Pharmaceutical Design|July 7, 2015
Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU EnvironmentCarlos J Madrid-Navarro, Rosa Sanchez-Galvez, Antonio Martinez-Nicolas, et al.Current Pharmaceutical Design|July 7, 2015
Disruption of Circadian Rhythms in Critical Illness - A Role of Hyperoxia-Induced Lung InjuryAlexander Czachor, Zachary Krueger, Young Cho, et al.Current Pharmaceutical Design|July 7, 2015
Disruption of Circadian Rhythms and Sleep in Critical Illness and its Impact on Innate ImmunityViola Dengler, Kristin Westphalen, Michael KoeppenCurrent Pharmaceutical Design|June 2, 2015
Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein DrugsJin Woo Park, Sun Jin Kim, Dong Sup Kwag, et al.Current Pharmaceutical Design|June 6, 2015
Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?Bart A Ellenbroek, Bibinaz GhiabiCurrent Pharmaceutical Design|June 20, 2015
Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future DirectionsMarine Mondino, Jerome Brunelin, Ulrich Palm, et al.Pageof 1,006